Role of Gut Microbial Metabolites in Ischemic and Non-Ischemic Heart Failure
Open Access
- 2 March 2025
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (5) , 2242
Abstract
The effect of the gut microbiota extends beyond their habitant place from the gastrointestinal tract to distant organs, including the cardiovascular system. Research interest in the relationship between the heart and the gut microbiota has recently been emerging. The gut microbiota secretes metabolites, including Trimethylamine N-oxide (TMAO), short-chain fatty acids (SCFAs), bile acids (BAs), indole propionic acid (IPA), hydrogen sulfide (H2S), and phenylacetylglutamine (PAGln). In this review, we explore the accumulating evidence on the role of these secreted microbiota metabolites in the pathophysiology of ischemic and non-ischemic heart failure (HF) by summarizing current knowledge from clinical studies and experimental models. Elevated TMAO contributes to non-ischemic HF through TGF-ß/Smad signaling-mediated myocardial hypertrophy and fibrosis, impairments of mitochondrial energy production, DNA methylation pattern change, and intracellular calcium transport. Also, high-level TMAO can promote ischemic HF via inflammation, histone methylation-mediated vascular fibrosis, platelet hyperactivity, and thrombosis, as well as cholesterol accumulation and the activation of MAPK signaling. Reduced SCFAs upregulate Egr-1 protein, T-cell myocardial infiltration, and HDAC 5 and 6 activities, leading to non-ischemic HF, while reactive oxygen species production and the hyperactivation of caveolin-ACE axis result in ischemic HF. An altered BAs level worsens contractility, opens mitochondrial permeability transition pores inducing apoptosis, and enhances cholesterol accumulation, eventually exacerbating ischemic and non-ischemic HF. IPA, through the inhibition of nicotinamide N-methyl transferase expression and increased nicotinamide, NAD+/NADH, and SIRT3 levels, can ameliorate non-ischemic HF; meanwhile, H2S by suppressing Nox4 expression and mitochondrial ROS production by stimulating the PI3K/AKT pathway can also protect against non-ischemic HF. Furthermore, PAGln can affect sarcomere shortening ability and myocyte contraction. This emerging field of research opens new avenues for HF therapies by restoring gut microbiota through dietary interventions, prebiotics, probiotics, or fecal microbiota transplantation and as such normalizing circulating levels of TMAO, SCFA, BAs, IPA, H2S, and PAGln.Keywords
Funding Information
- American Heart Association (24CDA1263497, R01HL162124, R01HL147586, 1R01HL174472, R01HL159865)
- National Institutes of Health (24CDA1263497, R01HL162124, R01HL147586, 1R01HL174472, R01HL159865)
This publication has 164 references indexed in Scilit:
- The potential preventive effect of probiotics, prebiotics, and synbiotics on cardiovascular risk factors through modulation of gut microbiota: A reviewFood Science & Nutrition, 2024
- The impact of probiotic yogurt versus ordinary yogurt on serum sTWEAK, sCD163, ADMA, LCAT and BUN in patients with chronic heart failure: a randomized, triple‐blind, controlled trialJournal of the Science of Food and Agriculture, 2022
- Impaired intestinal function is associated with lower muscle and cognitive health and well‐being in patients with congestive heart failureJournal of Parenteral and Enteral Nutrition, 2021
- Heart Failure is Associated with Depletion of Core Intestinal MicrobiotaESC Heart Failure, 2017
- Sodium Butyrate Protects Against High Fat Diet-Induced Cardiac Dysfunction and Metabolic Disorders in Type II Diabetic MiceJournal of Cellular Biochemistry, 2017
- TrimethylamineN‐oxide influence on the backbone of proteins: An oligoglycine modelProteins: Structure, Function, and Bioinformatics, 2009
- Effect of ursodeoxycholic acid on ischemia/reperfusion injury in isolated rat heartArchives of Pharmacal Research, 1999
- Glycine metabolism in anaerobesAntonie van Leeuwenhoek, 1994
- A Nomenclature for the Mammalian Flavin-Containing Monooxygenase Gene Family Based on Amino Acid Sequence IdentitiesArchives of Biochemistry and Biophysics, 1994
- Regulation of the trimethylamine N-oxide (TMAO) reductase in Escherichia coli: Analysis of tor::Mud1 operon fusionMolecular Genetics and Genomics, 1984